Holmes surrenders Theranos, pays $500K after ‘massive fraud’
NEW YORK — Elizabeth Holmes, a Stanford University dropout once billed as the “next Steve Jobs” has forfeited control of Theranos, the blood testing startup she founded, and will pay $500,000 to settle charges that she oversaw a “massive fraud.”
Under an agreement with the Securities and Exchange Commission, Holmes is barred from serving as an officer or director of a public company for 10 years. The SEC said Wednesday that it will pursue its case against the president of the company, Ramesh “Sunny” Balwani, in U.S. federal court.
The settlement comes two years after the SEC, prompted by a Wall Street Journal investigation, began looking into claims Theranos had made about its potentially revolutionary blood-testing technology.
The Journal quoted former employees that suspected the technology was a fraud, and it found that the company was using routine blood-testing equipment for the vast majority of its tests. The story raised concerns about the accuracy of Theranos’ blood testing technology, which put patients at risk of having conditions either misdiagnosed or ignored.
Holmes, 34, founded Theranos in Palo Alto, Calif., in 2003, pitching the company’s technology as a cheaper way to run dozens of blood tests. Once considered the nation’s youngest female billionaire, Holmes said she was inspired to start the company in response to her fear of needles.
Theranos raised millions in startup funding by promoting its tests as costing a “fraction” of what other labs charge.
At the centre of Theranos’ mystique was its “Edison” machine, which the company claimed could test for a variety of diseases through only a few drops of blood from a person’s finger. Despite the hype and company claims, Theranos shared few details on how its Edison machine – named after the inventor – worked.
Theranos attracted extraordinary interest and loaded its board with huge names, mainly elder Washington statesmen, including two former U.S. secretaries of state: Henry Kissinger and George Schultz. The group was criticized for lacking expertise in science or medicine.
Holmes kept strict control over her image, wearing only black turtleneck sweaters in public, much like Steve Jobs, was subject of several fawning profiles in business magazines and tech-focused news outlets.
Theranos’ intrigue went beyond just investors and the media. In 2015, Holmes was able to convince the Arizona State Legislature and Gov. Doug Ducey to pass a law allowing patients to get blood tests without a doctor’s order, for the direct benefit of Theranos. The company got Walgreens to open store-within-a-store concepts where customers could get their blood tested by Theranos.
After the Journal’s investigation, Theranos and Holmes pushed back hard, and for months refused to acknowledge that its machines were effectively a sham. State and federal authorities started investigations into the accuracy of the company’s blood testing work. In 2016 the Centers for Medicare and Medicaid Services, which oversees blood testing labs in the U.S., banned Holmes from operating a lab and revoked Theranos’ blood testing license.
In late 2016, Theranos began shutting down its clinical labs and wellness centres and laid off more than 40 per cent of its full-time employees. The company has been on life support ever since, and is rumoured to be close to bankruptcy.
Along with the fine announced Wednesday, Holmes agreed to return 18.9 million shares of Theranos that she obtained during the fraud. If the company is sold or liquidated in bankruptcy, Holmes will not profit from any remaining ownership in the company until at least $750 million in proceeds are returned to investors, the SEC said.
Theranos said Wednesday that neither the company nor Holmes admitted or denied wrongdoing.
SEATTLE — Only one of 118 gender discrimination complaints made by women at Microsoft was found to have merit, according to unsealed court documents.
The Seattle Times reports the records made public Monday illustrate the scope of complaints from female employees in technical jobs in the U.S. between 2010 and 2016. And according to the court documents, Microsoft’s internal investigations determined only one of those complaints was “founded.”
The company has denied that systemic bias is taking place through its employee-review process.
The documents were released as part of an ongoing lawsuit by three current or former Microsoft employees alleging gender discrimination.
The plaintiffs are seeking class-action status for the case, claiming more than 8,600 women collectively lost out on $238 million in pay and 500 promotions because of discrimination in the company’s performance review process.
Microsoft’s case is one of several against giant companies in the technology industry, which has been criticized in recent years for its lack of female and minority employees and for a workplace culture that some say is hostile toward those groups. Google, for example, is being sued by women who say they are underpaid compared to men at the company.
“Tech companies are absolutely lagging behind when it comes to gender inclusion,” Dnika J. Travis, a researcher at Catalyst, a non-profit that promotes inclusive workplaces for women, said in a statement.
The plaintiffs in the Microsoft case argue that men in similar roles with similar job performance were promoted faster and given more raises than their female colleagues.
Microsoft has said a class action isn’t warranted because there is no common cause for the employees’ complaints and plaintiffs have not identified systemic gender discrimination.
In court documents, Microsoft also has stood behind its internal investigative process, which involves a four-person team that looks into each complaint filed with the company. In a statement Tuesday, a Microsoft said all employee concerns are taken seriously and that the company has a “fair and robust system in place” to investigate them.
U.S. District Judge James Robart is hearing the case in U.S. District Court in Seattle and is expected to decide on the class-action request in the next several months.